Osaic Holdings’s ProMIS Neurosciences PMN Stock Holding History

Osaic Holdings’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.91K	Hold	360	–	–	﹤0.01%	7092
2026 Q2	$4.74K	Hold	360	–	–	﹤0.01%	6962
2026 Q1	$4.57K	Hold	360	–	–	﹤0.01%	6722
2025 Q4	$2.47K	Hold	360	–	–	﹤0.01%	7015
2025 Q3	$4.77K	Buy	+360	New	+$4.98K	﹤0.01%	6770

Other funds holding PMN

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Quadrature Capital London, United Kingdom $16.1B AUM 61.25% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Osaic Holdings's PMN Position: Q3 2026 in Review

Osaic Holdings held its ProMIS Neurosciences (PMN) position steady in Q3 2026 at 360 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7092.

Osaic Holdings first reported a position in PMN in Q3 2025 and has held it in 5 quarters since. The position peaked at $4.77K in Q3 2025. 7 funds tracked by Wall St. Rank hold PMN as of Q3 2026.

Osaic Holdings held 360 shares of ProMIS Neurosciences worth $3.91K as of Q3 2026.
Osaic Holdings left its ProMIS Neurosciences share count unchanged in Q3 2026.
ProMIS Neurosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7092 holding.
Osaic Holdings first reported a position in ProMIS Neurosciences in Q3 2025 and has held it in 5 quarters since.
Osaic Holdings's ProMIS Neurosciences position peaked at $4.77K in Q3 2025.
7 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.